PolyPid Valuation
| PYPD Stock | USD 3.55 0.12 3.50% |
At this time, the company appears to be undervalued. PolyPid holds a recent Real Value of $11.17 per share. The prevailing price of the company is $3.55. Our model determines the value of PolyPid from analyzing the company fundamentals such as Return On Equity of -4.97, shares outstanding of 6.8 M, and Shares Owned By Institutions of 36.74 % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting PolyPid's valuation include:
Price Book 11.1762 | Enterprise Value 24.6 M | Enterprise Value Ebitda (0.36) |
Undervalued
Today
Please note that PolyPid's price fluctuation is somewhat reliable at this time. Calculation of the real value of PolyPid is based on 3 months time horizon. Increasing PolyPid's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the PolyPid stock is determined by what a typical buyer is willing to pay for full or partial control of PolyPid. Since PolyPid is currently traded on the exchange, buyers and sellers on that exchange determine the market value of PolyPid Stock. However, PolyPid's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.55 | Real 11.17 | Target 34.67 | Hype 3.55 | Naive 3.49 |
The real value of PolyPid Stock, also known as its intrinsic value, is the underlying worth of PolyPid Company, which is reflected in its stock price. It is based on PolyPid's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of PolyPid's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of PolyPid helps investors to forecast how PolyPid stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of PolyPid more accurately as focusing exclusively on PolyPid's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use PolyPid's intrinsic value based on its ongoing forecasts of PolyPid's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against PolyPid's closest peers. If more than one evaluation category is relevant for PolyPid we suggest using both methods to arrive at a better estimate.
PolyPid Cash |
|
PolyPid Valuation Trend
Comparing PolyPid's enterprise value against its market capitalization is a good way to estimate the value of PolyPid uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
PolyPid Total Value Analysis
PolyPid is at this time projected to have valuation of 24.6 M with market capitalization of 24.12 M, debt of 11.78 M, and cash on hands of 23.78 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the PolyPid fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
24.6 M | 24.12 M | 11.78 M | 23.78 M |
PolyPid Asset Utilization
One of the ways to look at asset utilization of PolyPid is to check how much profit was generated for every dollar of assets it reports. PolyPid holds a negative application of assets of -0.65 pct., losing $0.006465 for each dollar of assets held by the company. Inadequate asset utilization implies the company is being less effective with each dollar of assets it holds. Put it differently, asset utilization of PolyPid shows how discouraging it operates for each dollar spent on its assets.PolyPid Ownership Allocation
The market capitalization of PolyPid is $24.12 Million. PolyPid has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.PolyPid Profitability Analysis
Net Loss for the year was (23.86 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates PolyPid's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in PolyPid and how it compares across the competition.
About PolyPid Valuation
The stock valuation mechanism determines PolyPid's current worth on a weekly basis. Our valuation model uses a comparative analysis of PolyPid. We calculate exposure to PolyPid's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of PolyPid's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -1.8 M | -1.9 M |
PolyPid Growth Indicators
Investing in growth stocks can be very risky. If the company such as PolyPid does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 1.4 M |
PolyPid Current Valuation Indicators
Valuation refers to the process of determining the present value of PolyPid and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value PolyPid we look at many different elements of the entity such as PolyPid's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as PolyPid, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use PolyPid's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes PolyPid's worth.Complementary Tools for PolyPid Stock analysis
When running PolyPid's price analysis, check to measure PolyPid's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PolyPid is operating at the current time. Most of PolyPid's value examination focuses on studying past and present price action to predict the probability of PolyPid's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PolyPid's price. Additionally, you may evaluate how the addition of PolyPid to your portfolios can decrease your overall portfolio volatility.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |